Grundschober C, Rufer N, Sanchez-Mazas A, Madrigal A, Jeannet M, Roosnek E, Tiercy J M
Transplantation Immunology Unit, Hôpitaux Universitaires de Genève, Switzerland.
Tissue Antigens. 1997 Jun;49(6):612-23. doi: 10.1111/j.1399-0039.1997.tb02809.x.
While the influence of HLA-AB and -DRB1 matching on the outcome of bone marrow transplantation (BMT) with unrelated donors is clear, the evaluation of HLA-C has been hampered by its poor serological definition. Because the low resolution of standard HLA-C typing could explain the significant number of positive cytotoxic T lymphocyte precursor frequency (CTLpf) tests found among HLA-AB-subtype, DRB1/B3/B5-subtype matched patient/donor pairs, we have identified by sequencing the incompatibilities recognized by CD8+ CTL clones obtained from such positive CTLpf tests. In most cases the target molecules were HLA-C antigens that had escaped detection by serology (e.g. Cw1601, 1502 or 0702). Direct recognition of HLA-C by a CTL clone was demonstrated by lysis of the HLA class I-negative 721.221 cell line transfected with Cw1601 cDNA. Because of the functional importance of Cw polymorphism, a PCR-SSO oligotyping procedure was set up allowing the resolution of 29 Cw alleles. Oligotyping of a panel of 382 individuals (including 101 patients and their 272 potential unrelated donors, 5 related donors and 4 platelet donors) allowed to determine HLA-C and HLA A-B-Cw-DRB1 allelic frequencies, as well as a number of A-Cw, B-Cw, and DRB1-Cw associations. Two new HLA-Cw alleles (Cw02023 and Cw0707) were identified by DNA sequencing of PCR-amplified exon 2-intron 2-exon 3 amplicons. Furthermore, we determined the degree of HLA-C compatibility in 287 matched pairs that could be formed from 73 patients and their 184 potential unrelated donors compatible for HLA-AB by serology and for HLA-DRB1/ B3/B5 by oligotyping. Cw mismatches were identified in 42.1% of these pairs, and AB-subtype oligotyping showed that 30% of these Cw-incompatible pairs were also mismatched for A or B-locus subtype. The degree of HLA-C incompatibility was strongly influenced by the linkage with B alleles and by the ABDR haplotypes. Cw alleles linked with B4403, B5101, B18, and B62 haplotypes were frequently mismatched. Apparently high resolution DNA typing for HLA-AB does not result in full matching at locus C. Since HLA-C polymorphism is recognized by alloreactive CTLs, such incompatibilities might be as relevant as AB-subtype mismatches in clinical transplantation.
虽然人类白细胞抗原A、B(HLA-AB)和DRB1配型对无关供者骨髓移植(BMT)结果的影响已很明确,但HLA-C的评估因血清学定义不佳而受到阻碍。由于标准HLA-C分型分辨率低,可能解释了在HLA-AB亚型、DRB1/B3/B5亚型匹配的患者/供者对中发现的大量阳性细胞毒性T淋巴细胞前体频率(CTLpf)检测结果,我们通过测序确定了从此类阳性CTLpf检测中获得的CD8⁺CTL克隆识别的不相容性。在大多数情况下,靶分子是血清学检测未发现的HLA-C抗原(如Cw1601、1502或0702)。用Cw1601 cDNA转染的HLA I类阴性721.221细胞系的裂解证明了CTL克隆对HLA-C的直接识别。由于Cw多态性的功能重要性,建立了一种聚合酶链反应-序列特异性寡核苷酸分型(PCR-SSO)程序,可分辨29个Cw等位基因。对382名个体(包括101名患者及其272名潜在无关供者、5名亲属供者和4名血小板供者)进行寡核苷酸分型,可确定HLA-C以及HLA A-B-Cw-DRB1等位基因频率,以及一些A-Cw、B-Cw和DRB1-Cw关联。通过对PCR扩增的外显子2-内含子2-外显子3扩增子进行DNA测序,鉴定出两个新的HLA-Cw等位基因(Cw02023和Cw新HLA-Cw等位基因(Cw02023和Cw0707)。此外,我们确定了73名患者及其184名通过血清学检测HLA-AB相容、通过寡核苷酸分型检测HLA-DRB1/B3/B5相容的潜在无关供者可形成的287对匹配对中的HLA-C相容程度。在这些对中,42.1%发现有Cw错配,AB亚型寡核苷酸分型显示,这些Cw不相容对中有百分之30在A或B位点亚型上也不匹配。HLA-C不相容程度受与B等位基因的连锁以及ABDR单倍型的强烈影响。与B4403、B5101、B18和B62单倍型连锁的Cw等位基因经常出现错配。HLA-AB的高分辨率DNA分型显然并未导致C位点完全匹配。由于同种反应性CTL可识别HLA-C多态性,这种不相容性在临床移植中可能与AB亚型错配同样重要。